In vivo administration of recombinant TNF-α promotes bone resorption in mice

Journal of Periodontal Research

Volumn 38, Issue 4, 2003, Pages 446-448

  Gaspersič, Rok ^a   Štiblar Martinčič, Draga ^a   Osredkar, Josko ^b   Skalerič, Uros ^a,c  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Bone; Mice; Tumor necrosis factor alpha

Indexed keywords

BUFFER; CALCIUM; PHOSPHATE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SODIUM CHLORIDE; PLACEBO; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; BONE METABOLISM; CALCIUM BLOOD LEVEL; CALVARIA; COLORIMETRY; CONTROLLED STUDY; DISEASE MODEL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; OSTEOCLAST; OSTEOLYSIS; OSTEOMETRY; PHOSPHATE BLOOD LEVEL; QUANTITATIVE ANALYSIS; SKULL; ANIMAL; BLOOD; BONE MARROW; C57BL MOUSE; CELL COUNT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; IMAGE PROCESSING; PARACRINE SIGNALING; PATHOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BONE MARROW; BONE RESORPTION; CALCIUM; CELL COUNT; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED C57BL; OSTEOCLASTS; PARACRINE COMMUNICATION; PARIETAL BONE; PHOSPHATES; PLACEBOS; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0141448853     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0765.2003.00662.x     Document Type: Article

References (12)

1. Listgarten MA. Nature of periodontal disease: pathogenic mechanisms. J Periodont Res 1987;22:172-178.
2. Genco RJ. Host responses in periodontal diseases: current concepts. J Periodontol 1992;63:338-355.
3. Thomson BM, Mundy GR, Chambers TJ. Tumor necrosis factor α and β induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 1987;138:775-779.
4. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factor. Nature 1986;319:516-518.
5. Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD. Interleukin 1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 1989;4:113-118.
6. Johnson RA, Boyce BF, Mundy GR, Roodman GD. Tumors producing human tumor necrosis factor induce hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology 1989;124:1424-1427.
7. Uy HL, Mundy GR, Boyce BF et al. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo. Cancer Res 1997;57:3194-3199.
8. Graves DT, Oskoui M, Volejnikova S et al. Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclasts formation in response to P. gingivalis infection. J Dent Res 2001;80: 1875-1879.
9. Sheehan KC, Ruddle NH, Schreiber RD. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 1989;142:3884-3893.
10. Bancroft JD, Cook HC, eds. Manual of histological techniques and their diagnostic applications. Edinburgh: Churchill Livingstone 1994.
11. Sabatini M, Boyce B, Aufdermorte T, Bonewald L, Mundy GR. Infusions of recombinant human interleukins 1α and 1β cause hypercalcemia in normal mice. Proc Natl Acad Sci USA 1988;85: 5235-5239.
12. Boyce BF, Aufdermorte TB, Garret IR, Yates AJP, Mundy GR. Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 1989;125:1142-1150.